Header:
CODE OF MARYLAND REGULATIONS
TITLE 10. DEPARTMENT OF HEALTH AND MENTAL HYGIENE
SUBTITLE 06. DISEASES
CHAPTER 01. COMMUNICABLE DISEASES AND RELATED CONDITIONS OF PUBLIC HEALTH IMPORTANCE
Date:
08/31/2009
Document:
.03 Reportable Diseases, Conditions, Outbreaks, and Unusual Manifestations; Submitting Clinical Materials.
A. A person, as set forth in Regulation .04 of this chapter, shall report the diseases or conditions listed in § C of this regulation, or any other condition as requested by the Secretary.
B. Within 1 working day of a positive laboratory finding for a disease or condition listed in § C of this regulation, or upon request of the Secretary, the director of a medical laboratory shall:
(1) Submit clinical material to the Department's public health laboratory; and
(2) Include information about the clinical material on a form provided by the Secretary.
C. List of Reportable Diseases and Conditions.
Diseases and Laboratory Submit Immediate Within
Conditions Evidence of 1
Clinical Working
Materials to Day
the Department
Department3/SUP>
(1) An outbreak of a Similar etiological X
disease of known or agents from a grouping
unknown etiology that or clustering of
may be a danger to the patients
public health4/SUP>
(2) A single case of a An etiologic agent X
disease or condition suspected to cause that
not otherwise included disease or condition
in this table of known
or unknown etiology,
that may be a danger to
the public health
(3) An unusual An etiologic agent X
manifestation of a suspected to cause that
communicable disease disease
in an individual
(4) Acquired Refer to COMAR 10.18 Refer to COMAR
immunodeficiency
syndrome (AIDS)5/SUP>
10.18
(5) Amebiasis Entamoeba histolytica X
(6) Anaplasmosis Anaplasma X
phagocytophilum
(7) Animal bites Not Applicable X
(8) Anthrax Bacillus anthracis X X
(9) Arboviral Any associated arbovirus X X
infections including, including, but not
but not limited to: limited to:
(a) Dengue fever; (a) Dengue virus;
(b) Eastern equine (b) Eastern equine
encephalitis; encephalitis virus;
(c) LaCrosse virus (c) LaCrosse virus;
infection; (d) St. Louis
(d) St. Louis encephalitis virus;
encephalitis; (e) Western equine
(e) Western equine encephalitis virus;
encephalitis; (f) West Nile virus;
(f) West Nile virus (g) Yellow fever virus
infection;
(g) Yellow fever
(10) Babesiosis Babesia species X
(11) Botulism Clostridium botulinum, X X
botulinum toxin, or
other botulism producing
Clostridia
(12) Brucellosis Brucella species X X
(13) Campylobacteriosis Campylobacter species X X
(14) Chancroid Haemophilus ducreyi X
(15) Chlamydia Chlamydia trachomatis X (if LGV X
trachomatis infection, strain)
including
lymphogranuloma
venereum (LGV)
(16) Cholera Vibrio cholerae X X
(17) Coccidioidomycosis Coccidioides immitis X
(18) Creutzfeldt-Jakob 14-3-3 protein from CSF X
disease or any brain pathology
suggestive of CJD
(19) Cryptosporidiosis Cryptosporidium species X
(20) Cyclosporiasis Cyclospora cayatensis X
(21) Diphtheria Corynebacterium X X
diphtheriae
(22) Ehrlichiosis Ehrlichia species X
(23) Encephalitis, Isolation from or X ( X
infectious demonstration in brain Infectious
tissue, central nervous agents as
system tissue, or indicated
cerebrospinal fluid, of elsewhere
any pathogenic organism in §C of
this
regulation
and viral
agents
except for
HSV)
(24) Epsilon toxin of Clostridium perfringens, X
Clostridium perfringens epsilon toxin
(25) Escherichia coli Escherichia coli O157:H7 X X
O157:H7 infection
(26) Giardiasis Giardia species X
(27) Glanders Burkholderia mallei X X
(28) Gonococcal Neisseria gonorrhoeae X
infection
(29) Haemophilus Haemophilus influenzae, X X
influenzae invasive isolated from a normally
disease sterile site
(30) Hantavirus Hantavirus X X
infection
(31) Harmful algal Not Applicable X
bloom related illness
(32) Hemolytic uremic Not Applicable X
syndrome,
post-diarrheal
(33) Hepatitis A acute Hepatitis A virus IgM X
infection
(34) Hepatitis, viral Hepatitis B, C, D, E, X
(B, C, D, E, G, all and G virus, other types
other types, and
undetermined)
(35) Human Refer to COMAR 10.18 Refer to COMAR
immunodeficiency virus 10.18
(HIV)5/sup>
(36) Influenza- Influenza X
associated pediatric virus-associated
mortality pediatric mortality in
persons younger than 18
years old (if known)
(37) Influenza: novel Isolation of influenza X X
influenza A virus virus from humans of a
infection novel or pandemic strain
(38) Isosporiasis Cystoisospora belli X
(synonym Isospora belli)
(39) Kawasaki syndrome Not Applicable X
(40) Legionellosis Legionella species X (if X
isolate
from
human)
(41) Leprosy Mycobacterium leprae X X
(42) Leptospirosis Leptospira interrogans X X
(43) Listeriosis Listeria monocytogenes X X
(44) Lyme disease Borrelia burgdorferi X
(45) Malaria Plasmodium species X X
(46) Measles (rubeola) Measles virus X
(47) Melioidosis Burkholderia X X
pseudomallei
(48) Meningitis, Isolation or X ( X
infectious demonstration of any Infectious
bacterial, fungal, or agents as
viral species in indicated
cerebrospinal fluid elsewhere
in §C of
this
regulation
and viral
agents
except for
HSV)
(49) Meningococcal Neisseria meningitidis X X
invasive disease (including serogroup,
if known), isolated from
a normally sterile site
(50) Microsporidiosis Various microsporidian X
protozoa, including but
not limited to
Encephalitozoon species
(51) Mumps (infectious Mumps virus X
parotitis)
(52) Mycobacteriosis, Mycobacterium spp., X
other than other than Mycobacterium
tuberculosis and tuberculosis complex or
leprosy Mycobacterium leprae
(53) Pertussis Bordetella pertussis X
(54) Pertussis vaccine Not Applicable X
adverse reactions
(55) Pesticide related Cholinesterase below the X
illness normal laboratory range
(56) Plague Yersinia pestis X X
(57) Pneumonia in a Various organisms X
health care worker
resulting in
hospitalization
(58) Poliomyelitis Poliovirus X X
(59) Psittacosis Chlamydophila psittaci X
(formerly Chlamydia
psittaci)
(60) Q fever Coxiella burnetii X X
(61) Rabies (human) Rabies virus X
(62) Ricin toxin Ricin toxin (from X
poisoning Ricinus communis castor
beans)
(63) Rocky Mountain Rickettsia rickettsii X
spotted fever
(64) Rubella (German Rubella virus X
measles) and
congenital rubella
syndrome
(65) Salmonellosis Salmonella species, X X
(nontyphoidal) including serogroup, if
known
(66) Severe acute SARS-associated X X
respiratory syndrome coronavirus (SARS-CoV)
(SARS)
(67) Shiga-like toxin Shiga toxin, shiga-like X X
producing enteric toxin, or the
bacterial infections toxin-producing
bacterium
(68) Shigellosis Shigella species, X X
including species or
serogroup, if known
(69) Smallpox and other Variola virus, vaccinia X X
orthopoxvirus virus, and other
infections orthopox viruses
(70) Staphylococcal Staphylococcus X
enterotoxin B poisoning enterotoxin B
(71) Streptococcal Streptococcus pyogenes, X X
invasive disease, Group A, isolated from
Group A a normally sterile site
(72) Streptococcal Streptococcus X X
invasive disease, Group agalactiae, Group B,
B isolated from a normally
sterile site
(73) Streptococcus Streptococcus pneumoniae X X
pneumoniae invasive , isolated from a
disease normally sterile site
(74) Syphilis Treponema pallidum X
(75) Tetanus Clostridium tetani X
(76) Trichinosis Trichinella spiralis X
(77) Tuberculosis and Mycobacterium X X
suspected tuberculosis complex
tuberculosis6 /sup>
(78) Tularemia Francisella tularensis X X
(79) Typhoid fever Salmonella Typhi X X
(case, carrier, or both
, of Salmonella Typhi)
(80) Vancomycin Intermediate resistance X X
-intermediate of the S. aureus
Staphylococcus aureus isolate to vancomycin
(VISA) infection or
colonization
(81) Vancomycin- Resistance of the S. X X
resistant aureus isolate to
Staphylococcus aureus vancomycin
(VRSA) infection or
colonization
(82) Varicella (chicken Varicella-zoster virus X
pox), fatal cases only (Human herpesvirus 3)
(83) Vibriosis, All non-cholera Vibrio X X
non-cholera7/sup> species7/sup>
(84) Viral hemorrhagic All hemorrhagic fever X
fevers (all types) viruses, including but
not limited to
Crimean-Congo, Ebola,
Marburg, Lassa, Machupo
viruses
(85) Yersiniosis Yersinia species X X
Footnotes:
1. As required to report in Regulation .04A(1)--(3), (5), and (6) of this chapter.
2. The timeframe for reporting is specified in Regulation .04C of this chapter.
3. Clinical material shall be submitted according to § B of this regulation.
4. Any grouping or clustering of patients having similar disease, symptoms, or syndromes that may indicate the presence of a disease outbreak.
5. Acquired immunodeficiency syndrome (AIDS) and human immunodeficiency virus (HIV), including CD4+ lymphocyte count and viral load, are reportable under COMAR 10.18.
6. Tuberculosis confirmed by culture and suspected tuberculosis as indicated by:
(a) A laboratory confirmed acid-fast bacillus on smear;
(b) An abnormal chest radiograph suggestive of active tuberculosis;
(c) A laboratory confirmed biopsy report consistent with active tuberculosis; or
(d) Initiation of two or more anti-tuberculosis medications.
7. Vibriosis, non-cholera, identified in any specimen taken from teeth, gingival tissues, or oral mucosa is not reportable.
|